Psoriasis and psoriatic arthritis have long been associated with cardiovascular disease and deaths, but now a large population study from Taiwan indicates the danger of cardiac arrhythmias is increased independently of traditional risk factors such as coronary disease and high blood pressure.
Study shows that adalimumab led to sustained clinical and functional responses in nearly one-third of treatment-refractory patients who completed 10 years of treatment. Patients with shorter disease duration achieved better outcomes, highlighting the need for early treatment.
Patients with chronic back and leg pain may be able to forgo the use of prescription painkillers thanks to a new treatment that has been shown to provide long-lasting analgesia.
A recent review looked at the immunopathogenesis of psoriasis, identified key mediators of psoriatic plaques that are being targeted by new and emerging biologic therapies, and highlighted the latest efficacy and safety data from trials of these new agents.
Evidence continues to emerge that biologics-in combination with DMARDS-offer a solid line of defense for patients with rheumatoid arthritis at risk of rapid disease progression .
Does timing really make an impact when it comes to treating back pain? A new study weighed in on the importance early initiation of therapy in this patient population.
Analysis of a population-based cohort indicates that patients with psoriasis and psoriatic arthritis face an elevated risk of developing heart arrhythmias such as atrial fibrillation.
Guselkumab, a selective antagonist of IL-23, went head to head with adalimumab in a year-long phase 2 trial of 293 patients with moderate to severe plaque psoriasis. A quick synopsis of the results here.
Hard, mobile, painless subcutaneous nodules developed in this woman who had had dermatomyositis for 20 years. The calcifications progressed during treatment with infliximab.
Here is the case of a 30-year-old man with scalp psoriasis in whom Koebner phenomenon developed at areas of developing shingles.
It may not be a surprise that having more gout flares in a year is more costly, but a recent study has quantified just how much more expensive they are.
A widely accessible medication commonly used to treat psychiatric disorders may also inhibit the damaging effects of osteoarthritis.
Tocilizumab treated rheumatoid arthritis patients are at an increased risk for major adverse cardiovascular events, according to a study published in Arthritis & Rheumatology.
Allopurinol's overall impact on the risk of mortality has been studied but is not yet well-understood. Now, a study has shown that the benefits from this treatment likely outweigh the risk of serious side effects.
Gout attacks really do occur more often at night, and here is proof. Theories abound as to why, but effective prophylactic treatments to reduce the risk of nocturnal exacerbations appear to be just what the doctor ordered.
Hand deformities seen in Jaccoud's arthropathy are the result of soft-tissue abnormalities, not the destruction of bone joints seen in rheumatoid arthritis.
Opioid analgesics are often prescribed to patients who suffer from chronic lower back pain; however, a new report suggests that these medications are less effective in a subset of these patients.
Not only have researchers uncovered a key factor that drives neuropathic pain, they have also identified a strategy to reverse it.
Researchers have found a genetic cause for the increased coronary artery disease risk experienced by some patients with migraine; however, this relationship may be limited to those who suffer from a specific kind of migraine.
Osteoarthritis (OA) is a crippling condition with the majority of cases taking place in the knee – but what's the best form of treatment?
The goal of 90% skin clearance is “reachable” for many patients with severe psoriasis with interleukin-17 (IL-17) inhibitors. A closer look here.
Weighing the pros and cons of prescription opioid use for chronic pain is an ongoing battle, and new research may have just added to the list of disadvantages.
Treatment with rituximab can significantly reduce rheumatoid arthritis flare up, according to results of a study published in the Journal of Clinical Rheumatology.
A new meta-study of bee venom therapy finds considerable risk of anaphylaxis and other reactions, concluding that only experts should offer it to patients.
How do patients with rheumatoid arthritis rate their health and well being? Their relationship with their physician? Two new surveys shed light.
The King v. Burwell US Supreme Court decision yesterday means that people who could have lost mental health insurance coverage don't have to worry.
Even if they have health insurance, some patients with rheumatoid arthritis may not be receiving adequate therapy.
In addition to killing emotions and proving to be ineffective for back pain and osteoarthritis, the most common drug ingredient in the US can also cause severe bodily harm.
The treatment window of opportunity for rheumatoid arthritis was debated in a recent editorial published in the Annals of Rheumatic Diseases.
There’s an app in development that could make it easier -- even fun-- for young children with juvenile idiopathic arthritis to describe where and how much they hurt.
